Electronic health records can be used to measure and record how guidelines are being implemented and followed, but more government intervention is needed to regulate electronic health records and set standards, Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Electronic health records can be used to measure and record how guidelines are being implemented and followed, but more government intervention is needed to regulate electronic health records and set standards, Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Transcript
Once guidelines have been implemented, what strategy should be in place to ensure they are consistently followed?
I think the key is measuring the use of guidelines and the type and patterns of treatment. We now, with all the electronic health records available, have mechanisms to measure what actually happens. Oftentimes, that isn’t done, so it becomes very important for physician leaders, the leader of the pharmacies that supply medications—either to individual practitioners or to group practitioners—to actually work together to measure outcomes, to record outcomes, and to know exactly what is being done.
We’ve had, over the years, a bit of a tendency of what you might call laissez-faire—leaving the people alone, hoping they’ll do the best job they can. And that’s a good implicit concept, but now that we have mechanisms to measure what we’re doing, we need to do that and then to implement those measurements, to understand the results of what we’re doing.
One of the biggest challenges is that so many of the electronic health record systems are so hard to use, they add a lot of working time to the average clinician’s day. And, unfortunately, most of the electronic health records are sold without any measure of government oversight or any requirement for the records to produce what they promise. So, this is going to have to be an area where government gets more actively involved in.
Today, you can sell an electronic health record, as far I know, to anybody. Given that it can have such a big impact on the delivery of healthcare, it’s probably time, in the same way that the physicians and the pharmaceutical industry are being regulated, I think it’s time for the government to start to look at the companies that make electronic health records and set standards of what they need to produce. That, in turn, will allow a much better level of systematization of care.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More